Search

The June 2010 issue of "Health and Stress: The Newsletter of The American Institute of Stress" is presented. It notes the move of the pharmaceutical companies to promote multiple medications to increase the income of executives and shareholders. It mentions the move of the Food and Drug Administration (FDA) to approve Fosamax to treat postmenopausal osteoposis.